Ilex's Leukemia Drug Shows Some Benefits-FDA Panel

SILVER SPRING, Md. (Reuters) - A panel of medical experts on Wednesday said Ilex Oncology Inc.'s new drug Clolar was "reasonably likely" to help children and young adults with a cancer called acute lymphocytic leukemia.

Continue to Ilex's Leukemia Drug Shows Some Benefits-FDA Panel on Reuters: Health.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz